Theraxyte

Genhe, Inner Mongolia, China

+86 010 8072 2985 ★

Company profile

Theraxyte company profile

TheraXyte BioScience is a biotechnology company focused on extracellular vesicle (EV)-mediated drug delivery and novel EV-based therapeutics. It aims to establish a multifunctional EV-based drug delivery platform that can meet the upcoming challenges of various therapeutic applications, driving EV research from the lab bench to the bedside, and making a positive impact on human health by overcoming unsolved challenges with novel EV-based therapeutics. TheraXyte has developed and continuously upgraded its EV-based drug delivery platform, TAXY, which could enable the mass production of modifiable EVs at the GMP manufacturing level, has the capability of effectively payload packaging, and target organs/cells of..... For more information, log in to dureach.com to view the full company profile.

Business identity

Website: http://theraxyte.com
Contact email: [email protected]
Phone number: +86 010 8072 2985
Operating status: Active
Company type: For Profit
Employee range: 00051-00100 employees
Founded: 2019-01-01

Headquarters

Headquarters: Genhe, Inner Mongolia, China
Country code: CN
Continent: Asia

Capital profile

Funding and company signals

Funding stage: Seed
Funding rounds: 1
Total equity funding: $10M
Last funding: Seed / $10M / 2022-07-11
Last equity funding: Seed / $10M
Investors: 1
Lead investors: 1

Categories and groups

Biopharma Biotechnology Health Care Medical Biotechnology Health Care Science and Engineering

Founders and investors

Lead investors

Novo Ventures

Investors

Novo Ventures

People at this company

Preview only. Contact details are available after you sign in.

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Shipment records and coverage can change as the dataset is updated.